ARX · ASX

Aroa Biosurgery Ltd (ASX:ARX)

AU$0.65

 0.015 (2.362%)
ASX:Live
21/11/2024 04:10:42 PM
Recent Earnings upgrade Hammer Bullish HALO Ords HALO Momentum HALO Growth +7
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ARX Overview

ARX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About ARX

Website

Aroa Biosurgery Ltd

Telephone

64.9.869.3035

Address

64 Richard Pearse Drive Mangere, Auckland 2022

Description

Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

ARX Price Chart

Key Stats

Market Cap

AU$224.19M

PE

673.00

EV/EBITDA

71.8

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.44 - 0.87

Trade Value (12mth)

US$44,788.00

1 week

0.79%

1 month

22.12%

YTD

-23.03%

1 year

-5.22%

All time high

1.75

Key Fundamentals

EPS 3 yr Growth

26.10%

EBITDA Margin

-4.50%

Operating Cashflow

-$7m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

-2.20

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

344m

HALO Sector

Healthcare

Next Company Report Date

20-May-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.17

ARX Announcements

Latest Announcements

Date Announcements

19 November 24

Notification of Half Year Results Webinar

×

Notification of Half Year Results Webinar

22 October 24

September 2024 Quarterly Report and Appendix 4C

×

September 2024 Quarterly Report and Appendix 4C

22 October 24

Investor Presentation

×

Investor Presentation

15 October 24

Notification of Quarterly Results Webinar

×

Notification of Quarterly Results Webinar

11 October 24

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

04 October 24

Change of Director's Interest Notice - CM

×

Change of Director's Interest Notice - CM

27 August 24

Change in substantial holding

×

Change in substantial holding

26 August 24

Change in substantial holding

×

Change in substantial holding

23 August 24

Notification regarding unquoted securities - ARX

×

Notification regarding unquoted securities - ARX

23 August 24

Application for quotation of securities - ARX

×

Application for quotation of securities - ARX

23 August 24

Application for quotation of securities - ARX

×

Application for quotation of securities - ARX

23 August 24

Section 708A Notice

×

Section 708A Notice

23 August 24

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

23 August 24

Change of Director's Interest Notice - BW

×

Change of Director's Interest Notice - BW

23 August 24

Change of Director's Interest Notice - DH

×

Change of Director's Interest Notice - DH

24 July 24

June 2024 Quarterly Report and Appendix 4C

×

June 2024 Quarterly Report and Appendix 4C

24 July 24

Investor Presentation

×

Investor Presentation

23 July 24

Chairman's Address - AGM

×

Chairman's Address - AGM

23 July 24

CEO Presentation - AGM

×

CEO Presentation - AGM

23 July 24

Results of Annual General Meeting

×

Results of Annual General Meeting

17 July 24

Notification of Quarterly Results Webinar

×

Notification of Quarterly Results Webinar

08 July 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

08 July 24

Proposed issue of securities - ARX

×

Proposed issue of securities - ARX

08 July 24

Proposed issue of securities - ARX

×

Proposed issue of securities - ARX

08 July 24

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

ARX Fundamentals

Per Share Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.03 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.5 -2,721.0 0.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 673.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 71.8 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 -0.00 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.03 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 793.4 -110.8 -1,000.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -2.5 -5.3 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.30 0.28 0.28 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.25 0.22 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.1 -11.0 -94.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 343 344 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 343 344 N/A Lock Lock Lock

Financial Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 63 69 69 Lock Lock Lock
     Growth % Lock Lock Lock Lock 59.7 9.0 -0.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 58 71 58 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 53 59 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 75.3 11.4 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 83.5 85.4 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 16 15 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -1 -8 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 82.0 -690.0 61.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.6 -11.5 -4.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 4 4 4 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -12 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.3 -154.6 14.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7.7 -17.9 -15.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 0 -12 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock 0 -11 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.3 -2,583.8 25.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.6 -15.4 -11.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -7 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 8 7 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 7 10 3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -11 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.7 -11.2 -4.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.2 -0.2 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 46 30 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 117 111 111 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 7 6 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -39 -23 -30 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 15 16 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 104 94 95 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 108 101 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -6.5 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -0.3 -9.6 -7.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -0.4 -11.3 -8.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -4.4 -11.7 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -0.4 -10.1 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -3.4 -7.0 N/A Lock Lock Lock

Ratios Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -2.7 -16.2 -2.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 38.8 2.9 9.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -37.4 -24.3 -31.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 9.9 7.3 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 9.3 6.4 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 59.0 43.8 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -47.7 -77.5 N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.9 2.5 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.3 1.6 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.9 1.2 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3.1 2.4 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -0.6 -17.5 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -0.3 -10.9 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -0.3 -9.6 -7.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -0.4 -11.3 -8.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -0.4 -11.3 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 157.1 232.6 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 126.3 144.0 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 283.4 376.7 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 53.2 49.8 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 230.2 326.9 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.17%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ARX Shortsell

Frequently Asked Questions

The current share price of Aroa Biosurgery Ltd (ARX:ASX) is AU$0.65.
The 52-week high share price for Aroa Biosurgery Ltd (ARX:ASX) is AU$0.87.
The 52-week low share price for Aroa Biosurgery Ltd (ARX:ASX)? is AU$0.44.
The current TTM dividend payout for Aroa Biosurgery Ltd (ARX:ASX) is 0.00.
Aroa Biosurgery Ltd (ARX:ASX) does not pay a dividend.
Aroa Biosurgery Ltd (ARX:ASX) has a franking level of 0.0%.
Aroa Biosurgery Ltd (ARX:ASX) is classified in the Healthcare.
The current P/E ratio for Aroa Biosurgery Ltd (ARX:ASX) is 673.00.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.